Tech Company Financing Transactions

Veralox Therapeutics Funding Round

Hatteras Venture Partners, Alexandria Venture Investments and Genesys Capital participated in a $16.6 million Series A capital raise for Veralox Therapeutics. This venture round was announced on 6/18/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

4539 Metropolitan Ct.
Frederick, MD 21704
USA

Phone

(301) 360-3502

Website

www.veralox.com

Email Address

[email protected]

Overview

We are developing first-in-class small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Strovel

        

Chief Medical Officer

Michael Hanna

        

Chief Operating Officer

Matthew Boxer

        

Chief Scientific Officer

David Maloney

        

VP - R & D

Michael Holinstat

        

Browse more venture capital transactions:

Prev: 6/18/2021: EnMass Energy venture capital transaction
Next: 6/18/2021: Unit Finance venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary